Early Clinical Data Raise the Bar for Hemophilia Gene Therapies
Oct 11, 2016
Several gene therapy companies reported promising early clinical data in July showing that they could restore healthy blood clotting factor levels in people with severe hemophilia.
Continue reading here.
The new fiber-optic probe could transform aneurysm and brain clot treatments
Drug trial results show that vaccines aren't the only use for the mRNA technology behind the most widely used COVID-19 jabs.